Literature DB >> 26830020

Vagus Nerve Stimulation Improves Cardiac Function by Preventing Mitochondrial Dysfunction in Obese-Insulin Resistant Rats.

Bencharunan Samniang1,2,3, Krekwit Shinlapawittayatorn1,2,3, Titikorn Chunchai1,2,3, Wanpitak Pongkan1,2,3, Sirinart Kumfu1,2,3, Siriporn C Chattipakorn1,2,3,4, Bruce H KenKnight5, Nipon Chattipakorn1,2,3.   

Abstract

Long-term high-fat diet (HFD) consumption leads to not only obese-insulin resistance, but also impaired left ventricular (LV) function. Vagus nerve stimulation (VNS) has been shown to exert cardioprotection. However, its effects on the heart and metabolic parameters under obese-insulin resistant condition is not known. We determined the effects of VNS on metabolic parameters, heart rate variability (HRV) and LV function in obese-insulin resistant rats. Male Wistar rats were fed with HFD for 12 weeks, and were randomly divided into sham and VNS groups. VNS was applied for the next 12 weeks. Echocardiography, blood pressure and HRV were examined. Blood samples were collected for metabolic parameters. At the end, the heart was removed for determination of apoptosis, inflammation, oxidative stress, and cardiac mitochondrial function. VNS for 12 weeks significantly decreased plasma insulin, HOMA index, total cholesterol, triglyceride, LDL and visceral fat. Serum adiponectin was significantly increased in the VNS group. VNS also significantly decreased blood pressure, improved HRV and LV function, decreased cardiac MDA, TNF-α and Bax levels, and improved cardiac mitochondrial function. VNS improves metabolic and hemodynamic parameters, and the LV function via its ability against apoptosis, inflammation and oxidative stress, and preserved cardiac mitochondrial function in obese-insulin resistant rats.

Entities:  

Mesh:

Year:  2016        PMID: 26830020      PMCID: PMC4735283          DOI: 10.1038/srep19749

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  47 in total

1.  Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose.

Authors:  Jin-Shang Wu; Yi-Ching Yang; Thy-Sheng Lin; Ying-Hsiang Huang; Jia-Jin Chen; Feng-Hwa Lu; Chih-Hsing Wu; Chih-Jen Chang
Journal:  J Clin Endocrinol Metab       Date:  2007-07-31       Impact factor: 5.958

Review 2.  Sympathetic overdrive and cardiovascular risk in the metabolic syndrome.

Authors:  Guido Grassi
Journal:  Hypertens Res       Date:  2006-11       Impact factor: 3.872

3.  Oxidative stress in a rat model of obesity-induced hypertension.

Authors:  A D Dobrian; M J Davies; S D Schriver; T J Lauterio; R L Prewitt
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  PPARγ agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets.

Authors:  Noppamas Pipatpiboon; Wasana Pratchayasakul; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

6.  Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats.

Authors:  Nattayaporn Apaijai; Hiranya Pintana; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

7.  Decreased plasma adiponectin concentrations in women with dyslipidemia.

Authors:  Miyao Matsubara; Shoji Maruoka; Shinji Katayose
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

8.  Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.

Authors:  Toshimasa Yamauchi; Junji Kamon; Hironori Waki; Yasushi Imai; Nobuhiro Shimozawa; Kyouji Hioki; Shoko Uchida; Yusuke Ito; Keisuke Takakuwa; Junji Matsui; Makoto Takata; Kazuhiro Eto; Yasuo Terauchi; Kajuro Komeda; Masaki Tsunoda; Koji Murakami; Yasuyuki Ohnishi; Takeshi Naitoh; Kenichi Yamamura; Yoshito Ueyama; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

Review 9.  Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information.

Authors:  Anthony J Barron; Nabeela Zaman; Graham D Cole; Roland Wensel; Darlington O Okonko; Darrel P Francis
Journal:  Int J Cardiol       Date:  2013-06-21       Impact factor: 4.164

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  11 in total

Review 1.  Effects of vagal neuromodulation on feeding behavior.

Authors:  Nicole A Pelot; Warren M Grill
Journal:  Brain Res       Date:  2018-02-07       Impact factor: 3.252

Review 2.  The possible factors affecting microglial activation in cases of obesity with cognitive dysfunction.

Authors:  Titikorn Chunchai; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Metab Brain Dis       Date:  2017-11-21       Impact factor: 3.584

3.  Early Weight Loss Independent Effects of Sleeve Gastrectomy on Diet-Induced Cardiac Dysfunction in Obese, Wistar Rats.

Authors:  Tammy L Kindel; Tom Foster; Paul Goldspink; Steven J Kindel; John Corbett; Michael Widlanksy; Jennifer Strande
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

4.  Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin-resistant rats.

Authors:  Wannipa Tunapong; Nattayaporn Apaijai; Sakawdaurn Yasom; Pongpan Tanajak; Keerati Wanchai; Titikorn Chunchai; Sasiwan Kerdphoo; Sathima Eaimworawuthikul; Parameth Thiennimitr; Anchalee Pongchaidecha; Anusorn Lungkaphin; Wasana Pratchayasakul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Eur J Nutr       Date:  2017-06-12       Impact factor: 5.614

5.  Parasympathetic neural activity and the reciprocal regulation of innate antiviral and inflammatory genes in the human immune system.

Authors:  Richard P Sloan; Steve W Cole
Journal:  Brain Behav Immun       Date:  2021-08-13       Impact factor: 7.217

6.  Stochastic vagus nerve stimulation affects acute heart rate dynamics in rats.

Authors:  Steven W Lee; Kanchan Kulkarni; Elizabeth M Annoni; Imad Libbus; Bruce H KenKnight; Elena G Tolkacheva
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

7.  Short-term discontinuation of vagal nerve stimulation alters 18F-FDG blood pool activity: an exploratory interventional study in epilepsy patients.

Authors:  Ellen Boswijk; Renee Franssen; Guy H E J Vijgen; Roel Wierts; Jochem A J van der Pol; Alma M A Mingels; Erwin M J Cornips; Marian H J M Majoie; Wouter D van Marken Lichtenbelt; Felix M Mottaghy; Joachim E Wildberger; Jan Bucerius
Journal:  EJNMMI Res       Date:  2019-11-27       Impact factor: 3.138

8.  Vagus nerve stimulation optimized cardiomyocyte phenotype, sarcomere organization and energy metabolism in infarcted heart through FoxO3A-VEGF signaling.

Authors:  Bin Luo; Yan Wu; Shu-Lin Liu; Xing-Yuan Li; Hong-Rui Zhu; Lei Zhang; Fei Zheng; Xiao-Yao Liu; Ling-Yun Guo; Lu Wang; Hong-Xian Song; Yan-Xia Lv; Zhong-Shan Cheng; Shi-You Chen; Jia-Ning Wang; Jun-Ming Tang
Journal:  Cell Death Dis       Date:  2020-11-12       Impact factor: 8.469

9.  Non-invasive vagus nerve stimulation attenuates proinflammatory cytokines and augments antioxidant levels in the brainstem and forebrain regions of Dahl salt sensitive rats.

Authors:  Madhan Subramanian; Laura Edwards; Avery Melton; Lyndee Branen; Angela Herron; Mahesh Kumar Sivasubramanian; Raisa Monteiro; Samantha Stansbury; Priya Balasubramanian; Lynsie Morris; Khaled Elkholey; Monika Niewiadomska; Stavros Stavrakis
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

10.  Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats.

Authors:  Suwakon Wongjaikam; Sirinart Kumfu; Juthamas Khamseekaew; Jirapas Sripetchwandee; Somdet Srichairatanakool; Suthat Fucharoen; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.